Navigation Links
Study Examines Media Preferences of Life Scientists in Applied Markets

ARLINGTON, Va., Jan. 4 /PRNewswire/ -- Faced with modest growth in the traditional life science market, suppliers are turning their attention to opportunities in agricultural, biodefense and molecular diagnostics. To help companies navigate these unfamiliar waters, leading research and advisory firm BioInformatics, LLC today released its latest report examining the marketing and media preferences of scientists working in these dynamic markets. The report, "Marketing to Life Scientists: Capturing Customers' Attention in Applied Markets" highlights the importance of effective marketing in capturing mindshare in markets where product differentiation can be hard to achieve.

A complimentary Executive Summary of the report is available at:

"This report can help life science companies determine the right combination of marketing messages and tactics to efficiently reach their target audience in these applied markets," said Tamara Zemlo, PhD, Director of Syndicated Research at BioInformatics, LLC. "Scientists working in these fields share many similarities with those in basic research and drug discovery, but there are also some striking differences that marketers can exploit for optimal effectiveness."

The scientists surveyed also ranked the effectiveness of their suppliers' marketing programs in terms of "best" Web site, print catalog, exhibits, print advertising and sales force. While hundreds of companies were mentioned, market leaders such as Bio-Rad Laboratories (Amex: BIO), BD Biosciences (NYSE: BDX), Invitrogen (Nasdaq: IVGN), Sigma-Aldrich (Nasdaq: SIAL), Thermo Fisher Scientific (NYSE: TMO), and New England Biolabs all received exceptionally high rankings in multiple categories.

"When the data is analyzed by segment, however, it's clear that some firms have been more successful than others in raising awareness of their brands in the agricultural, biodefense and molecular diagnostics markets," observed Zemlo.

Key findings of the report will be shared in a complimentary Webinar presented on January 15, 2008 at 1:00 p.m. ET. To register to attend the Webinar, please email


BioInformatics, LLC is the premier research and advisory firm serving the life science industry. By leveraging our professional social network of more than 35,000 biomedical researchers, we have supported more than 300 companies and provided insights that lead to better business decisions. Our assignments include assessing the size and attractiveness of markets, optimizing product configurations and pricing, validating corporate acquisitions, measuring customer loyalty, and evaluating brand strength and positioning.

For more information, please contact:

Catherine Seguin

Director of Communications

BioInformatics, LLC

2111 Wilson Blvd., Suite 250

Arlington, VA 22201

703.778.3080 x13 (phone)

SOURCE BioInformatics, LLC
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Triage study challenges notions of emergency medical response to disaster
2. Federally-Funded Study Shows More Women Can Avoid Hysterectomy for Common Problem
3. Genmab A/S - R1507 Antibody to Enter Phase II Study to Treat Sarcoma
4. Study Reaffirms Superiority of Trofile(TM) Assay
5. Genzyme Study of Myozyme(R) for Late-Onset Pompe Patients Meets Co-Primary Efficacy Endpoints
6. Genmab Announces Details of Planned Ofatumumab Phase II Study in Multiple Sclerosis
7. Nastech Enters Into Feasibility Study to Develop a Non-Injectable Dosage Form of Factor IX to Control Bleeding
8. National Cancer Institute Study to Determine the Optimal Time for CLL Patients to Begin Treatment
9. Berlin Heart Enrolls First Patient in US Multi-Center EXCOR(R) Pediatric VAD IDE Study
10. Genmab Announces Update on Recruitment of Patients in ofatumumab CLL Pivotal Study
11. STALLERGENES: ORALAIR Grasses: Positive Results of VO52.06 Paediatric Study
Post Your Comments:
(Date:10/8/2015)... Maryland , October 8, 2015 ... .   --> Goldman Small ... in the small cap and microcap sectors, announced ... research report on PharmaCyte Biotech, Inc. (OTCQB - ... focused on developing and preparing treatments for cancer ...
(Date:10/8/2015)... , Oct. 8, 2015 /PRNewswire/ - RepliCel Life Sciences Inc. ... company focused on the development of autologous cell therapies, today ... partnering meetings taking place in the month of October: ... Partnering Forum RepliCel will be presenting at the ... on the Mesa to be held October 7-9 in ...
(Date:10/8/2015)... Claremont, CA (PRWEB) , ... October 08, 2015 ... ... by mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene and results ... abnormally viscous and sticky mucus accumulates in the lungs. This mucus is very ...
(Date:10/7/2015)... , Oct. 7, 2015  ChromaDex Corp. ... and nutritional ingredients that creates science-based solutions for ... nutrition, and pharmaceutical products, today announced that the ... CEO and Founder, is now available for on-demand ... -->   --> ...
Breaking Biology Technology:
... , ... , Formation of new blood ... been the focus of many drug screening and cell signaling research studies. Blood ... tumors, and is implicated in wound healing, retinopathy and macular degeneration. , ...
... , Tran T. Nham Varian Australia ... Introduction , Because ... with an ICP spectrometer, it has been widely used to determine trace ... work was to evaluate the ability of the ultrasonic nebulizer to handle ...
... Varian, Inc. , Introduction ... are veterinary drugs. The use of these in food production is ... and the European Union because of a possible increased cancer-risk through ... of nitrofurans contamination has been found in warm-water prawns, shrimp, and ...
Cached Biology Technology:
(Date:9/10/2015)... LONDON , Sept. 10, 2015 This ... dominate wearable technology products today, and emerging sensor types ... have risen through the peak of the wearable technology ... the slide to disillusionment. The common feature with all ... the key enabler for their most useful functions. Sensors ...
(Date:9/9/2015)... Columbia , Sept. 9, 2015  NuData ... organizational and solution-based milestones, furthering the company,s commitment ... of online fraud. NuData Security,s online ... enhancing the company,s growth cycle. The product combines ... to determine good user behavior from fraudulent behavior, ...
(Date:9/2/2015)... California , September 2, 2015 ... the security purpose implied in a system which ... geometry, voice, signature, iris, vein, DNA and finger ... has forced to develop such system which provides ... username, password, PIN, Patterns and tokens are vulnerable ...
Breaking Biology News(10 mins):
... MAMMALS could be at a greater risk of extinction due ... published today by the Zoological Society of London (ZSL). ... with information of where droughts and cyclones are most likely ... risk of exposure to extreme weather. The paper, published this ...
... WASHINGTON D.C. -- Secretary of Energy Steven Chu was among ... NSF,s Graduate Research Fellowship Program (GRFP) today. GRFP is ... engineering fields within NSF,s mission. It has been in ... in students with demonstrated potential for significant achievements in science ...
... synchronize their movements. For example, the footsteps of two ... consciously aware that it is happening. Similarly, the clapping ... Although this type of synchronous body movement has been ... social interactions remain obscure. In a new study, led ...
Cached Biology News:
... human XAB2 (amino terminus) XAB2 (XPA-binding ... interaction with XPA. Immunoprecipitation experiments have also ... with the transcription-coupled repair-specific proteins CSA and ... II. Microinjection experiments with XAB2 antibodies resulted ...
... maintenance, calibration, and validation (MCV) ... 96-well plate used for hands-free ... procedures using the Bio-Plex suspension ... is for use with Bio-Plex ...
Biology Products: